Medicinal Species: Phytochemistry, Biosynthesis, and Bioactivities.

Cheng-Peng Sun, Zi-Li Jia, Xiao-Kui Huo, Xiang-Ge Tian, Lei Feng, Chao Wang, Bao-Jing Zhang, Wen-Yu Zhao, Xiao-Chi Ma

Journal: The American journal of Chinese medicine 2021;49(2):315-358

PMID: 33622212

Abstract

As a genus of the Asteraceae, is widely distributed all over the world, and several of them are being used in traditional medicines. A number of metabolites were isolated from species, and some of these have shown to possess ranges of pharmacological activities. The genus contains abundant sesquiterpenoids, such as eudesmanes, xanthanes, and sesquiterpenoid dimers and trimers. In addition, other types of terpenoids, flavonoids, and lignins also exist in the genus . Since 2010, more than 300 new secondary metabolites, including several known natural products that were isolated for the first time from the genus . Most of them exhibited potential bioactivities in various diseases. The review aimed to summarize the advance of recent researches (2010-2020) on phytochemical constituents, biosynthesis, and pharmacological properties of the genus for providing a scientific basis and supporting its application and exploitation for new drug development.

Address: Dalian Key Laboratory of Metabolic Target, Characterization and Traditional Chinese, Medicine Intervention, College of Pharmacy, Institute of Integrative Medicine, Dalian, Medical University, Dalian, P. R. China.; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, P. R. China.; School of Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, P. R. China.

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.